Rushita Bagchi
Concepts (182)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Histone Deacetylases | 6 | 2023 | 47 | 2.550 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 7 | 2018 | 44 | 2.510 |
Why?
| Myocardium | 9 | 2022 | 443 | 2.230 |
Why?
| Fibroblasts | 9 | 2022 | 386 | 1.780 |
Why?
| Myofibroblasts | 9 | 2022 | 48 | 1.590 |
Why?
| Gene Expression Regulation | 11 | 2022 | 1063 | 1.480 |
Why?
| Collagen Type I | 4 | 2016 | 97 | 1.470 |
Why?
| Adipocytes | 3 | 2023 | 128 | 1.140 |
Why?
| Myocytes, Cardiac | 5 | 2020 | 137 | 1.040 |
Why?
| Epigenesis, Genetic | 4 | 2020 | 399 | 0.880 |
Why?
| Obesity | 4 | 2022 | 1203 | 0.850 |
Why?
| Energy Metabolism | 5 | 2022 | 311 | 0.840 |
Why?
| Transcription Factors | 5 | 2019 | 622 | 0.820 |
Why?
| Animals | 32 | 2023 | 14409 | 0.800 |
Why?
| Lysine | 1 | 2022 | 102 | 0.800 |
Why?
| Histone Deacetylase Inhibitors | 4 | 2023 | 56 | 0.790 |
Why?
| Mice | 20 | 2023 | 6428 | 0.750 |
Why?
| Cardiomegaly | 2 | 2022 | 38 | 0.740 |
Why?
| Genome, Human | 1 | 2020 | 131 | 0.710 |
Why?
| Thermogenesis | 2 | 2023 | 22 | 0.710 |
Why?
| Adipose Tissue, Brown | 2 | 2023 | 45 | 0.700 |
Why?
| Pulmonary Artery | 1 | 2020 | 152 | 0.670 |
Why?
| Molecular Targeted Therapy | 1 | 2018 | 128 | 0.620 |
Why?
| Lung | 2 | 2022 | 508 | 0.620 |
Why?
| NIH 3T3 Cells | 6 | 2018 | 55 | 0.600 |
Why?
| Fatty Liver | 1 | 2018 | 129 | 0.600 |
Why?
| Fibronectins | 1 | 2016 | 41 | 0.570 |
Why?
| Mice, Knockout | 5 | 2022 | 927 | 0.570 |
Why?
| Transcriptional Activation | 5 | 2018 | 134 | 0.550 |
Why?
| Gene Expression | 2 | 2015 | 664 | 0.540 |
Why?
| Transforming Growth Factor beta | 6 | 2020 | 158 | 0.530 |
Why?
| Luciferases | 1 | 2015 | 57 | 0.530 |
Why?
| High-Throughput Screening Assays | 1 | 2015 | 37 | 0.520 |
Why?
| Genes, Reporter | 1 | 2015 | 98 | 0.520 |
Why?
| Diabetes Mellitus | 1 | 2019 | 309 | 0.520 |
Why?
| Quality of Life | 1 | 2020 | 924 | 0.470 |
Why?
| Inflammation | 5 | 2020 | 678 | 0.470 |
Why?
| Smad Proteins | 1 | 2012 | 13 | 0.440 |
Why?
| Extracellular Matrix | 5 | 2021 | 111 | 0.430 |
Why?
| Acute Kidney Injury | 3 | 2022 | 404 | 0.410 |
Why?
| Heart | 4 | 2020 | 361 | 0.410 |
Why?
| Signal Transduction | 7 | 2022 | 1752 | 0.410 |
Why?
| Ventricular Remodeling | 2 | 2022 | 65 | 0.400 |
Why?
| Oxidative Stress | 4 | 2022 | 958 | 0.400 |
Why?
| Mice, Inbred C57BL | 7 | 2022 | 2001 | 0.390 |
Why?
| Rats, Sprague-Dawley | 7 | 2019 | 1664 | 0.350 |
Why?
| Ischemia | 2 | 2021 | 177 | 0.340 |
Why?
| Asthma | 4 | 2012 | 293 | 0.330 |
Why?
| Humans | 22 | 2023 | 54391 | 0.310 |
Why?
| Fibrosis | 4 | 2022 | 209 | 0.300 |
Why?
| Promoter Regions, Genetic | 5 | 2018 | 520 | 0.300 |
Why?
| Nuclear Proteins | 2 | 2019 | 253 | 0.300 |
Why?
| E-Box Elements | 3 | 2018 | 4 | 0.300 |
Why?
| Transforming Growth Factor beta1 | 2 | 2016 | 66 | 0.260 |
Why?
| Transcription, Genetic | 2 | 2018 | 418 | 0.260 |
Why?
| Heart Failure | 2 | 2022 | 541 | 0.260 |
Why?
| Male | 14 | 2022 | 27347 | 0.260 |
Why?
| 3T3-L1 Cells | 2 | 2022 | 16 | 0.250 |
Why?
| Base Sequence | 3 | 2016 | 719 | 0.250 |
Why?
| Rats | 9 | 2019 | 3419 | 0.250 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2017 | 435 | 0.240 |
Why?
| Muscle, Smooth | 3 | 2012 | 68 | 0.240 |
Why?
| Catecholamines | 1 | 2023 | 48 | 0.240 |
Why?
| Myocytes, Smooth Muscle | 3 | 2012 | 92 | 0.230 |
Why?
| Models, Biological | 3 | 2022 | 825 | 0.230 |
Why?
| Metabolome | 2 | 2021 | 109 | 0.220 |
Why?
| Diet, High-Fat | 3 | 2022 | 216 | 0.220 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 9 | 0.220 |
Why?
| Acylation | 1 | 2022 | 7 | 0.210 |
Why?
| Cells, Cultured | 5 | 2019 | 1737 | 0.210 |
Why?
| RNA-Binding Proteins | 2 | 2013 | 136 | 0.210 |
Why?
| Phenotype | 5 | 2016 | 819 | 0.200 |
Why?
| GATA4 Transcription Factor | 1 | 2020 | 13 | 0.200 |
Why?
| Acute Lung Injury | 1 | 2021 | 19 | 0.200 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 18 | 0.200 |
Why?
| Heart Murmurs | 1 | 2021 | 15 | 0.200 |
Why?
| Myofibrils | 1 | 2020 | 21 | 0.190 |
Why?
| Leptin | 1 | 2022 | 154 | 0.190 |
Why?
| Induced Pluripotent Stem Cells | 1 | 2020 | 44 | 0.190 |
Why?
| Disease Models, Animal | 4 | 2021 | 1647 | 0.190 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2020 | 151 | 0.180 |
Why?
| Pulmonary Disease, Chronic Obstructive | 2 | 2012 | 133 | 0.180 |
Why?
| Adenosine Triphosphate | 1 | 2021 | 242 | 0.180 |
Why?
| Pneumonia | 1 | 2021 | 129 | 0.180 |
Why?
| Heart Failure, Diastolic | 1 | 2019 | 1 | 0.170 |
Why?
| Cardio-Renal Syndrome | 1 | 2019 | 1 | 0.170 |
Why?
| Actins | 2 | 2016 | 132 | 0.170 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 151 | 0.170 |
Why?
| Isoenzymes | 1 | 2019 | 177 | 0.170 |
Why?
| NF-E2-Related Factor 2 | 1 | 2019 | 63 | 0.170 |
Why?
| Protein Binding | 3 | 2019 | 736 | 0.160 |
Why?
| Chromatin | 1 | 2019 | 156 | 0.160 |
Why?
| Gene Deletion | 2 | 2017 | 293 | 0.160 |
Why?
| Transfection | 2 | 2018 | 399 | 0.160 |
Why?
| Adipose Tissue, White | 1 | 2018 | 39 | 0.160 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2018 | 64 | 0.160 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2018 | 53 | 0.160 |
Why?
| Dual-Specificity Phosphatases | 1 | 2017 | 2 | 0.160 |
Why?
| Feedback, Physiological | 1 | 2017 | 19 | 0.160 |
Why?
| Phosphorylation | 2 | 2017 | 613 | 0.160 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 206 | 0.150 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 101 | 0.150 |
Why?
| Smad3 Protein | 1 | 2016 | 9 | 0.140 |
Why?
| Casein Kinase II | 1 | 2016 | 11 | 0.140 |
Why?
| Serine | 1 | 2016 | 44 | 0.140 |
Why?
| Amino Acid Substitution | 1 | 2016 | 105 | 0.140 |
Why?
| Cell Line | 2 | 2016 | 1152 | 0.140 |
Why?
| Insulin Resistance | 1 | 2018 | 300 | 0.140 |
Why?
| Histones | 2 | 2020 | 335 | 0.130 |
Why?
| Connective Tissue Growth Factor | 1 | 2015 | 10 | 0.130 |
Why?
| Biotin | 1 | 2015 | 45 | 0.130 |
Why?
| Pancreas | 1 | 2015 | 80 | 0.130 |
Why?
| Cloning, Molecular | 1 | 2015 | 198 | 0.130 |
Why?
| Pyridones | 1 | 2015 | 42 | 0.130 |
Why?
| Apoptosis | 1 | 2020 | 1302 | 0.120 |
Why?
| Angiotensin II | 1 | 2015 | 167 | 0.120 |
Why?
| Hypertension, Pulmonary | 2 | 2013 | 126 | 0.120 |
Why?
| Adenylate Kinase | 1 | 2013 | 10 | 0.120 |
Why?
| Cell Differentiation | 1 | 2016 | 720 | 0.110 |
Why?
| Genes, Dominant | 1 | 2012 | 21 | 0.110 |
Why?
| Sensitivity and Specificity | 1 | 2015 | 922 | 0.110 |
Why?
| Receptors, Estrogen | 1 | 2012 | 131 | 0.110 |
Why?
| Heart Diseases | 1 | 2015 | 239 | 0.110 |
Why?
| Adipose Tissue | 2 | 2023 | 208 | 0.100 |
Why?
| Molecular Sequence Data | 1 | 2012 | 980 | 0.090 |
Why?
| Aged, 80 and over | 1 | 2018 | 3431 | 0.090 |
Why?
| Aged | 2 | 2022 | 10060 | 0.080 |
Why?
| Reactive Oxygen Species | 2 | 2022 | 491 | 0.080 |
Why?
| Mutation | 1 | 2012 | 1504 | 0.070 |
Why?
| Cell Proliferation | 3 | 2016 | 1097 | 0.070 |
Why?
| Female | 3 | 2021 | 28471 | 0.060 |
Why?
| Cell Movement | 2 | 2016 | 271 | 0.060 |
Why?
| Middle Aged | 1 | 2018 | 13082 | 0.060 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 206 | 0.050 |
Why?
| Mice, Obese | 1 | 2022 | 22 | 0.050 |
Why?
| Adult | 1 | 2018 | 14207 | 0.050 |
Why?
| Muscle Contraction | 2 | 2012 | 111 | 0.050 |
Why?
| Enzyme Activation | 1 | 2022 | 328 | 0.050 |
Why?
| Embryo, Mammalian | 1 | 2020 | 69 | 0.050 |
Why?
| Azepines | 1 | 2019 | 22 | 0.040 |
Why?
| RNA Polymerase II | 1 | 2019 | 17 | 0.040 |
Why?
| Oxadiazoles | 1 | 2019 | 13 | 0.040 |
Why?
| Enhancer Elements, Genetic | 1 | 2019 | 64 | 0.040 |
Why?
| Body Weight | 1 | 2022 | 578 | 0.040 |
Why?
| Cell Adhesion Molecules | 1 | 2019 | 87 | 0.040 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 99 | 0.040 |
Why?
| Benzamides | 1 | 2019 | 54 | 0.040 |
Why?
| Mitochondria, Heart | 1 | 2019 | 42 | 0.040 |
Why?
| Triazoles | 1 | 2019 | 119 | 0.040 |
Why?
| 3T3 Cells | 1 | 2018 | 52 | 0.040 |
Why?
| HEK293 Cells | 1 | 2019 | 245 | 0.040 |
Why?
| Estrogens | 1 | 2020 | 244 | 0.040 |
Why?
| Dose-Response Relationship, Drug | 1 | 2022 | 1476 | 0.040 |
Why?
| Metabolomics | 1 | 2019 | 149 | 0.040 |
Why?
| Genetic Vectors | 1 | 2018 | 139 | 0.040 |
Why?
| Repressor Proteins | 1 | 2019 | 165 | 0.040 |
Why?
| Heart Ventricles | 1 | 2019 | 271 | 0.040 |
Why?
| Transcriptome | 1 | 2019 | 346 | 0.040 |
Why?
| Focal Adhesions | 1 | 2016 | 12 | 0.040 |
Why?
| Analysis of Variance | 1 | 2018 | 634 | 0.040 |
Why?
| DNA Methylation | 1 | 2020 | 575 | 0.040 |
Why?
| Echocardiography | 1 | 2019 | 392 | 0.030 |
Why?
| Microarray Analysis | 1 | 2015 | 85 | 0.030 |
Why?
| Liver | 1 | 2022 | 1226 | 0.030 |
Why?
| Models, Cardiovascular | 1 | 2015 | 29 | 0.030 |
Why?
| RNA, Messenger | 1 | 2017 | 1203 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2018 | 1551 | 0.030 |
Why?
| Kidney | 1 | 2019 | 822 | 0.030 |
Why?
| Chromatin Immunoprecipitation | 1 | 2013 | 55 | 0.030 |
Why?
| Bronchoconstriction | 1 | 2012 | 10 | 0.030 |
Why?
| Airway Remodeling | 1 | 2012 | 2 | 0.030 |
Why?
| DNA Primers | 1 | 2012 | 225 | 0.030 |
Why?
| Bronchial Hyperreactivity | 1 | 2012 | 6 | 0.030 |
Why?
| Cellular Microenvironment | 1 | 2012 | 27 | 0.030 |
Why?
| Hyperplasia | 1 | 2012 | 107 | 0.030 |
Why?
| Hypertrophy | 1 | 2012 | 55 | 0.030 |
Why?
| Chemokines | 1 | 2012 | 96 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2012 | 128 | 0.030 |
Why?
| Dietary Supplements | 1 | 2015 | 457 | 0.030 |
Why?
| Muscle, Smooth, Vascular | 1 | 2012 | 140 | 0.020 |
Why?
| Diet | 1 | 2015 | 598 | 0.020 |
Why?
| Cytokines | 1 | 2012 | 677 | 0.020 |
Why?
|
|
Bagchi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|